// Sheng Chen 1,* , Binjie Zhao 1,* , Wei Wang 1,* , Ligen Shi 1 , Cesar Reis 2,3 and Jianmin Zhang 1 1 Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, PR China 2 Department of Physiology and Pharmacology, Loma Linda University, Loma Linda, California, USA 3 Department of Preventive Medicine, Loma Linda University, Loma Linda, California, USA * The first three authors have contributed equally to the work Correspondence to: Jianmin Zhang, email: // or zjm135@zju.edu.cn Keywords : intracerebral hemorrhage, hematoma expansion, predictor Received : March 24, 2017 Accepted : June 19, 2017 Published : July 18, 2017 Abstract Despite years of effort, intracerebral hemorrhage (ICH) remains the most devastating form of stroke with more than 40% 30-day mortality worldwide. Hematoma expansion (HE), which occurs in one third of ICH patients, is strongly predictive of worse prognosis and potentially preventable if high-risk patients were identified in the early phase of ICH. In this review, we summarize data from recent studies on HE prediction and classify those potential indicators into four categories: clinical (severity of consciousness disturbance; blood pressure; blood glucose at and after admission); laboratory (hematologic parameters of coagulation, inflammation and microvascular integrity status), radiographic (interval time from ICH onset; baseline volume, shape and density of hematoma; intraventricular hemorrhage; especially the spot sign and modified spot sign) and integrated predictors (9-point or 24-point clinical prediction algorithm and PREDICT A/B). We discuss those predictors’ underlying pathophysiology in HE and present opportunities to develop future therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: